Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by AstraZeneca Pharmaceuticals (Ireland) DAC naming Pádraig O'Sullivan .
Filed returns
13
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Rare disease policy and access to medicines (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Joint Committee on Health session on the treatment of rare diseases (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Inequity of access to innovative oncology medicines for patients in Ireland (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Sharing a Proposal for an Early Access Programme for Innovative Oncology Medicines Budget 2026 (Matters involving public funds) | 27 | On lobbying.ie |
| May–Aug 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Cork office launch event (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Programme for Government priorities and rare disease medicines access policy (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Engagement regarding access to orphan medicines and national rare disease plan (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Meeting request to discuss AstraZeneca Ireland's health policy priorities (Public policy or programme) | 11 | On lobbying.ie |
| Jan–Apr 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | To discuss trends in access to rare disease medicines for Irish patients. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 7 | On lobbying.ie |
| Sep–Dec 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 4 | On lobbying.ie |
| May–Aug 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 5 | On lobbying.ie |
| Jan–Apr 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 10 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 13 | 100.0% |